What is the alternate day prophylactic dose of Septran DS (trimethoprim and sulfamethoxazole) for a child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternate Day Prophylactic Dose of Septran DS for Children

The recommended alternate day prophylactic dose of Septran DS (trimethoprim-sulfamethoxazole) for children is 8 mg/kg/day of trimethoprim component, which can be administered three consecutive days per week as an alternative to daily administration. 1

Dosage Calculation and Administration

  • For prophylaxis in children, the FDA recommends 750 mg/m² per day of sulfamethoxazole with 150 mg/m² per day of trimethoprim given orally in equally divided doses twice a day, on 3 consecutive days per week 2
  • The total daily prophylactic dose should not exceed 1600 mg sulfamethoxazole and 320 mg trimethoprim 2
  • For children older than 2 months, the dose is calculated based on the trimethoprim component at 8 mg/kg/day divided into two doses 1, 2
  • For a standard prophylactic regimen, this dose can be administered on alternate days or three consecutive days per week 1

Administration Guidelines by Age/Weight

  • Infants less than 2 months of age: Trimethoprim-sulfamethoxazole is contraindicated 3, 2
  • Children 2 months and older: Use weight-based dosing of 8 mg/kg/day of trimethoprim component 1, 2
  • Dosing guide by body surface area (for 3 days per week prophylaxis) 2:
    • Body surface area 0.26-0.53 m²: ½ tablet every 12 hours
    • Body surface area 1.06 m²: 1 tablet every 12 hours

Indications for Prophylaxis

  • Prophylaxis for Pneumocystis jiroveci pneumonia in immunocompromised children 1
  • Prevention of recurrent urinary tract infections 4, 5
  • Post-exposure prophylaxis for certain infections (as an alternative agent) 1

Monitoring and Safety Considerations

  • Regular monitoring should include complete blood counts with differential and platelet counts at initiation of prophylaxis and monthly thereafter 1
  • Long-term low-dose prophylaxis has proven very effective with minimal adverse effects in children 4, 5
  • The incidence of adverse reactions in children on prophylactic doses is significantly lower than in those on full therapeutic doses 5
  • Common side effects include rash, gastrointestinal disturbances, and hematologic abnormalities, though these are rare at prophylactic doses 1, 5

Important Precautions

  • Trimethoprim-sulfamethoxazole is contraindicated in infants younger than 2 months due to the potential risk for kernicterus 3, 2
  • The drug should be used with caution in patients with impaired hepatic and renal functions 3
  • If life-threatening toxicity occurs, the drug should be permanently discontinued 1
  • Adequate fluid intake should be maintained to prevent crystalluria and renal stones 3

Clinical Efficacy

  • Studies have shown that prophylactic use of trimethoprim-sulfamethoxazole at appropriate doses is highly effective in preventing reinfections 4
  • In one study, only 6 of 130 children receiving prophylactic treatment developed reinfection during a total period of 2637 months 4
  • The safety profile for long-term prophylaxis in children is excellent, with serious side effects being extremely rare and most being reversible upon discontinuation of therapy 5

References

Guideline

Prophylaxis with Septran DS in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.